Skip to main content
Top
Published in: Breast Cancer Research and Treatment 3/2008

01-06-2008 | Letter to the Editor

Identification of rare complete BRCA1 gene deletion using a combination of SNP haplotype analysis, MLPA and array-CGH techniques

Authors: Michal Konecny, Katarina Zavodna, Vladimira Vranova, Miriam Vizvaryova, Eva Weismanova, Iveta Mlkva, Petr Kuglik, Juraj Kausitz, Zdena Bartosova

Published in: Breast Cancer Research and Treatment | Issue 3/2008

Login to get access

Excerpt

Large genomic rearrangements (LGRs) escape detection by PCR based methods such as SSCP and DNA sequencing. Although multiplex-ligation-dependent probe amplification (MLPA), developed for detection of LGRs, is fast and easy to perform [1], still in many laboratories PCR-based techniques remain the first step in mutational screening of patients with hereditary breast and ovarian cancer (HBOC) as LGRs are much less frequent than point/small mutations in some populations [24], making MLPA prior to DNA sequencing only marginally cost-effective. Alternatively, detection of unusual BRCA1 SNP haplotypes in an affected individual may be suggestive of hemizygous regions caused by LGRs [59]. However, this latter approach focused only on the index case would not detect complete gene deletions that do not disturb the usual haplotypes. Herein, we report a way how the SNP haplotype analysis of the BRCA1 gene in members within a HBOC family may lead to identification of a complete gene deletion. …
Literature
1.
go back to reference Schouten JP, McElgunn CJ, Waaijer R et al (2002) Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acid Res 30:e57PubMedCrossRef Schouten JP, McElgunn CJ, Waaijer R et al (2002) Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acid Res 30:e57PubMedCrossRef
2.
go back to reference Hartmann C, John AL, Klaes R et al (2004) Large BRCA1 gene deletions are found in 3% of German high-risk breast cancer families. Hum Mutat 24:534PubMedCrossRef Hartmann C, John AL, Klaes R et al (2004) Large BRCA1 gene deletions are found in 3% of German high-risk breast cancer families. Hum Mutat 24:534PubMedCrossRef
3.
go back to reference Bunyan DJ, Eccles DM, Sillibourne J et al (2004) Dosage analysis of cancer predisposition genes by multiplex ligation-dependent probe amplification. Br J Cancer 91:1155–1159PubMedCrossRef Bunyan DJ, Eccles DM, Sillibourne J et al (2004) Dosage analysis of cancer predisposition genes by multiplex ligation-dependent probe amplification. Br J Cancer 91:1155–1159PubMedCrossRef
4.
go back to reference de la Hoya M, Gutiérrez-Enríquez S, Velasco E et al (2006) Genomic rearrangements at the BRCA1 locus in Spanish families with breast/ovarian cancer. Clin Chem 52:1480–1485PubMedCrossRef de la Hoya M, Gutiérrez-Enríquez S, Velasco E et al (2006) Genomic rearrangements at the BRCA1 locus in Spanish families with breast/ovarian cancer. Clin Chem 52:1480–1485PubMedCrossRef
5.
go back to reference Montagna M, Dalla Palma M, Menin C et al (2003) Genomic rearrangements account for more than one-third of the BRCA1 mutations in northern Italian breast/ovarian cancer families. Hum Mol Genet 12:1055–1061PubMedCrossRef Montagna M, Dalla Palma M, Menin C et al (2003) Genomic rearrangements account for more than one-third of the BRCA1 mutations in northern Italian breast/ovarian cancer families. Hum Mol Genet 12:1055–1061PubMedCrossRef
6.
go back to reference Woodward AM, Davis TA, Silva AG et al (2005) Large genomic rearrangements of both BRCA2 and BRCA1 are a feature of the inherited breast/ovarian cancer phenotype in selected families. J Med Genet 42:e31PubMedCrossRef Woodward AM, Davis TA, Silva AG et al (2005) Large genomic rearrangements of both BRCA2 and BRCA1 are a feature of the inherited breast/ovarian cancer phenotype in selected families. J Med Genet 42:e31PubMedCrossRef
7.
go back to reference Hendrickson BC, Pruss D, Lyon E, Scholl T (2003) Application of haplotype pair analysis for the identification of hemizygous loci. J Med Genet 40:346–347PubMedCrossRef Hendrickson BC, Pruss D, Lyon E, Scholl T (2003) Application of haplotype pair analysis for the identification of hemizygous loci. J Med Genet 40:346–347PubMedCrossRef
8.
go back to reference Ward BD, Hendrickson BC, Judkins T et al (2005) A multi-exonic BRCA1 deletion identified in multiple families through single nucleotide polymorphism haplotypes pair analysis and gene amplification with widely dispersed primer sets. J Mol Diagn 7:139–142PubMed Ward BD, Hendrickson BC, Judkins T et al (2005) A multi-exonic BRCA1 deletion identified in multiple families through single nucleotide polymorphism haplotypes pair analysis and gene amplification with widely dispersed primer sets. J Mol Diagn 7:139–142PubMed
9.
go back to reference Tancredi M, Sensi E, Cipollini G et al (2004) Haplotype analysis of BRCA1 gene reveals a new gene rearrangement: characterization of a 19.9 KBP deletion. Eur J Hum Genet 12:775–777PubMedCrossRef Tancredi M, Sensi E, Cipollini G et al (2004) Haplotype analysis of BRCA1 gene reveals a new gene rearrangement: characterization of a 19.9 KBP deletion. Eur J Hum Genet 12:775–777PubMedCrossRef
10.
go back to reference Shattuck-Eidens D, Oliphant A, McClure M et al (1997) BRCA1 sequence analysis in women at high risk for susceptibility mutations. Risk factor analysis and implications for genetic testing. JAMA 278:1242–1250PubMedCrossRef Shattuck-Eidens D, Oliphant A, McClure M et al (1997) BRCA1 sequence analysis in women at high risk for susceptibility mutations. Risk factor analysis and implications for genetic testing. JAMA 278:1242–1250PubMedCrossRef
11.
go back to reference Konstantopoulou I, Kroupis CH, Ladopoulou A et al (2000) BRCA1 mutation analysis in breast/ovarian cancer families from Greece. Hum Mutat 16:272–273PubMedCrossRef Konstantopoulou I, Kroupis CH, Ladopoulou A et al (2000) BRCA1 mutation analysis in breast/ovarian cancer families from Greece. Hum Mutat 16:272–273PubMedCrossRef
Metadata
Title
Identification of rare complete BRCA1 gene deletion using a combination of SNP haplotype analysis, MLPA and array-CGH techniques
Authors
Michal Konecny
Katarina Zavodna
Vladimira Vranova
Miriam Vizvaryova
Eva Weismanova
Iveta Mlkva
Petr Kuglik
Juraj Kausitz
Zdena Bartosova
Publication date
01-06-2008
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 3/2008
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-007-9670-0

Other articles of this Issue 3/2008

Breast Cancer Research and Treatment 3/2008 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine